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Background/aim: The aim of this study was to assess the risk of malnutrition in hospitalized patients with three different tests and to
compare these tests in terms of long hospitalization periods and sarcopenia.
Materials and methods: Hospitalized patients in an internal medicine clinic were enrolled in this cross-sectional study. Patients were
grouped as under 65 years (Group 1 = G1) and over 65 years old (Group 2 = G2). The nutritional status of the patients was evaluated
with the Nutritional Risk Screening (NRS) 2002, Universal Malnutrition Screening Tool (MUST), Mini Nutritional Assessment Short
Form (MNA-SF), and total Mini Nutritional Assessment (MNA) tests. Diagnosis of sarcopenia was assessed via bioimpedance analysis
for muscle mass, a hand-grip strength test, and a “timed get up and go” test. Nutritional tests were compared in terms of sarcopenia and
long hospitalization periods with receiver operating characteristic curve analysis.
Results: Mean ages were 54 (G1, n = 84) and 76 (G2, n = 112) years old. Sarcopenia was found in 5% in G1 and 33% in G2. The MNASF in G1 (area under curve (AUC) = 0.585, P = 0.26; sensitivity 41%, specificity 44%) and the MUST in G2 (AUC = 0.614, P = 0.048;
25%, 86%) were better predictors of prolonged hospitalization. The MNA-SF was associated with sarcopenia in both groups (G1: AUC
= 0.716, P = 0.147; 63%, 64% and G2: AUC = 0.762, P < 0.001; 86%, 48%). In addition, the MNA-SF was a better predictor of low lean
muscle mass index (AUC = 0.762, P < 0.001; 86%, 48%), low grip strength (AUC = 0.594, P = 0.27; 65%, 50%), and reduced walking
speed (AUC = 0.642, P = 0.01; 71%, 47%) in G2.
Conclusion: None of the three tests are highly sensitive or specific for predicting sarcopenia. The MNA-SF is a better test to evaluate
sarcopenia and/or related parameters than the others, and the MUST is related to prolonged hospitalization in older patients.
Key words: Hospitalized patients, long hospitalization period, malnutrition, sarcopenia

1. Introduction
Malnutrition is an important cause of mortality and
morbidity in hospitalized patients (1), with a prevalence
rate of 32%–50% in hospitalized adult patients (2).
Malnutrition prevalence increases with age and number of
comorbid diseases (3). Malnutrition is an important cause
of secondary sarcopenia (3,4), and it has been found that
the presence of sarcopenia in hospitalized, malnourished
patients is related to increased mortality rates (5). Thus,
diagnosing sarcopenia in hospitalized patients (especially
older adults) is important for estimating mortality and
morbidity. Malnutrition and sarcopenia, one of its negative
* Correspondence: drwalker@mynet.com.tr
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consequences, are also associated with a prolonged
hospitalization period (6–8).
Although there are many screening and diagnostic
tools, including biochemical markers and anthropometric
measures, there is no single test for evaluating nutritional
status and its negative consequences in hospitalized
patients. The Nutritional Risk Screening 2002 (NRS 2002)
test for hospitalized patients (9), the Mini Nutritional
Assessment (MNA) for elderly outpatients (10,11), and
the Universal Malnutrition Screening Tool (MUST) for
population screening (12) are commonly used to evaluate
malnutrition risks (1). In previous studies, these tests were
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compared with each other in pairs (13,14) or in threes (15)
to determine malnutrition status, mortality, prolonged
hospitalization periods, and disease complications in
hospitalized patients.
In practice, we thought that these tests could be used
to predict the presence of sarcopenia due to their easy
applicability and because of the malnutrition–sarcopenia
relationship. However, as far as we know, there have been
no studies comparing the relationship of malnutrition
status with sarcopenia and/or lean muscle mass index
(LMMI), hand grip strength, and walking speed using
the three tests. Therefore, the aims of our study were to
evaluate malnutrition risk in hospitalized patients in
internal medicine inpatient clinics using the three different
tests and to compare these tests in terms of predicting
sarcopenia and prolonged hospitalization periods.
2. Materials and methods
2.1. Study design and participants
Patients admitted to internal medicine inpatient clinics
at the Cerrahpaşa School of Medicine (excluding the
oncology, hematology, and rheumatology clinics) between
October 2013 and January 2014 were included in this
cross-sectional study. The patients were examined in two
groups: those less than 65 years of age (Group 1 = G1) and
those over 65 years of age (Group 2 = G2). Demographic
information, comorbid diseases, and the number of
medications used by these patients were recorded.
Many methods are used to identify sarcopenia, and there
are no assigned cutoff points in the devices used in its
diagnosis in the Turkish population. In order to reflect the
healthy population of Turkey in an effective manner, we
enrolled 30 healthy male and 30 healthy female volunteer
controls between the ages of 20 and 40. Volunteers had no
chronic disease, had no history of medication use for any
reason, and did not actively exercise (Table 1). The mean
age was 30.8 ± 5.3 years in females and 28.2 ± 4.1 years
in males. The study had the approval of the local ethics
committee and the participants provided written informed
consent.
2.2. Nutritional evaluation
Within the first 72 h after being hospitalized, each
patient’s nutritional status was evaluated by the research
assistants on the team using the NRS 2002 (9), MUST
(12), MNA Short Form (MNA-SF) (10), and MNA total
tests (11). All of the nutrition tests were administered
by the same researcher. Malnutrition risk was defined
as ≥3 points on the NRS 2002, ≥2 points on the MUST,
≤11 points on the MNA-SF, and 17.5–23.5 points on the
total MNA. Anthropometric measures (height, weight,
and arm and calf circumferences) were recorded. Body
mass index (BMI) (kg/m2) was measured using height
(m) and weight (kg) measurements. Hospitalization

periods were calculated by evaluating hospitalization and
discharge time. A long hospitalization period was defined
as hospitalization of over 15 days.
2.3. Evaluation of sarcopenia
Sarcopenia was staged in three phases, namely
presarcopenia, sarcopenia, and severe sarcopenia, by the
European Working Group on Sarcopenia in Older People,
formed by the European Union Geriatric Medicine Society
(4). In the presarcopenia stage, there is only loss of muscle
mass; muscle strength and performance are normal. In the
sarcopenia stage, there are loss of muscle mass and effects
on muscle strength and/or performance. In the severe
sarcopenia stage, muscle mass, strength, and performance
severely decline.
2.3.1. Evaluation of muscle mass
Bioimpedance analysis (BIA) is a method that evaluates
muscle and fat mass in a cost-effective and easy manner,
and it can be performed quickly in both hospitalized and
ambulatory patients. In this study, the multifrequency,
quarter-electrode BIA device Bodystat QuadScan 4000
(Bodystat Ltd., Isle of Man, UK) was used to measure
the LMMI of the patients. All measurements were taken
by the same researcher in accordance with the literature
(16). Patients with contraindications to performing
a BIA analysis, such as patients with prostheses,
pacemakers, or diseases affecting BIA analysis results (e.g.,
decompensated congestive heart failure (NYHA III–IV),
massive pleural effusion, acute or chronic kidney failure
with hypervolemia, pregnancy, or severe muscle disorder),
were excluded from the study. The patient’s data were
acquired and recorded by the device after a fasting period
of 4 h. Four electrodes were placed on the patient’s upper
and lower extremities with the patient lying in a supine
position for approximately 4–5 min. LMMI (kg/m2) was
calculated automatically with special equations from the
device. The LMMIs of the controls were also calculated
automatically by the device according to the individual’s
sex. In accordance with the literature, the muscle mass was
accepted as declining if the LMMI of the patient was less
than the cutoff point of –2 standard deviations (SDs) of the
mean LMMI values of the healthy controls (Table 1) (17).
The cutoff points of our healthy control group are similar
to the results of a previous study made using the same BIA
device in a Caucasian population (18).
2.3.2. Muscle strength evaluation
The hand grip strength test is an easily applicable,
inexpensive, and simple test performed with an isometric
hand dynamometer. In this study, a Jamar model hand
dynamometer (Model SH500L, Four D Rubber Company
Ltd., Derbyshire, UK) was used to measure the hand grip
strength of the patients. The dominant hand was designated
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by asking the patient which hand was more actively used.
Measurements were performed by the same researcher in
accordance with the literature (19). The patient was seated
in a chair with elbows and arms on the table. The arms
were flexed at 90° and positioned parallel to the ground.
Three measurements were performed on both arms, with
a 1-min rest period between each measurement. The mean
of the three measurements was calculated; muscle strength
was accepted as low when the hand grip strength test of the
patient was below the cutoff point of –2 SDs of the mean
hand grip strength (kg) of the healthy controls, grouped
according to sex (Table 1).
2.3.3. Muscle performance evaluation
The physical performances of the patients were evaluated
with a “timed get up and go” test. In this test, while being
timed, the patient starts from a seated position on a chair,
gets up from the chair without any support, walks 3 m,
turns and comes back, and sits back down on the chair
without support. In this study, the walking speeds of the
patients were calculated with a chronometer. Muscle
performance was accepted as low if the test period was
≥15 s (20).
2.4. Statistical analysis
All data were analyzed using SPSS 15.0 for Windows
(SPSS Inc., Chicago, IL, USA). Demographic and clinical
properties, malnutrition, and sarcopenia status were
presented as basic clinical data. Student’s t-test was used
to compare numerical variables between groups, and chisquare tests were used to compare categorical variables.
Nutritional tests were compared in terms of prolonged
hospitalization period (≥15 days), sarcopenia, and its
parameters (LMMI, hand grip strength, and walking
speed) using receiver operating characteristic (ROC) curve
analysis. P < 0.05 was accepted as statistically significant.
Values were represented as mean ± SD.

3. Results
Sixty controls and 206 hospitalized patients were included
in the study. Ten patients were excluded due to the
inability to measure muscle mass because of technical
problems. Table 2 presents the distribution of the
groups, the demographic and clinical properties, and the
sarcopenia and malnutrition measurements of the 196
patients. There were no differences in sex distribution
between the groups (P = 0.38). G2 had a statistically higher
number of comorbidities, but there were no statistically
significant differences between the groups in the number
of medications used (P = 0.001 and P = 0.13, respectively).
There were no significant differences in BMI between
the groups in terms of anthropometric measurements.
However, arm and calf circumference were significantly
lower in G2, as expected (P = 0.001). Forty-six patients
(23.5%) included in the study could not perform the
“timed get up and go” test due to their clinical status,
and they were not included in the mean walking speed
measurements shown in Table 2.
Thirty-four patients in G2 (30%) could not perform
the “timed get up and go” test. The mean walking speed
of G2 was calculated as 14.8 s. However, when the number
of patients who were unable to perform the test was taken
into consideration, this value was expected to be higher.
The walking speeds of the patients who could not
perform the “timed get up and go” test were accepted
as low in the sarcopenia assessment. Table 3 shows the
malnutrition risks and sarcopenia of all of the patients
according to the three tests. Malnutrition risk and
sarcopenia ratio were higher in G2, as expected.
The presence of malnutrition was significantly
correlated with the presence of sarcopenia in our study
(P < 0.001). The negative predictive value was 50%, and
the positive predictive value was 85% when comparing the

Table 1. Cutoff points of lean muscle mass index and hand grip strength calculated according
to healthy controls.
Sex

Female (n = 30)

Male (n = 30)

30.8 ± 5.3

28.2 ± 4.1

LMMI (kg/m )

15.7 ± 1.13

20.2 ± 1.50

–2 SD

13.4

17.1

Hand grip strength (R) (kg)

29.3 ± 5.4

44.3 ± 7.4

–2 SD

18.5

29.5

Hand grip strength (L) (kg)

27.1 ± 4.7

39.8 ± 8.3

–2 SD

17.7

23.2

Age
2

LMMI: Lean muscle mass index; SD: standard deviation.
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Table 2. Demographic and clinical properties, sarcopenia, and malnutrition measurement values of all patients.
G1 (n = 84)

G2 (n = 112)

P-value*

Sex (female/male)

45/39

68/44

0.38**

Mean age ± SD

54 ± 7.01

76.6 ± 8

<0.001

Mean comorbid disease ± SD

2.5 ± 1.5

3.3 ± 1.9

0.001

Mean number of medication ± SD

6.35 ± 5.2

7.3 ± 3.7

0.13

Mean hospitalization period ± SD (days)

29.3 ± 19.6

21.5 ± 14.5

0.002

Mean BMI ± SD (kg/m )

29.3 ± 7.3

28 ± 6

0.09

Mean arm circumference ± SD (cm)

29.6 ± 4.3

27.4 ± 4.4

0.001

Mean calf circumference ± SD (cm)

37 ± 4.7

34.2 ± 6.2

0.001

Mean LMMI ± SD (kg/m )

18.3 ± 2.7

15.9 ± 3

<0.001

Mean hand grip strength ± SD (kg)

21.2 ± 9.1

13.8 ± 8.3

<0.001

Mean walking speed ± SD (s)

10.5 ± 4.2

14.8 ± 7.2

<0.001

Mean NRS 2002 ± SD (points)

1.5 ± 0.99

2.4 ± 1.25

<0.001

Mean MUST ± SD (points)

0.6 ± 1.26

1.03 ± 1.42

0.03

Mean MNA-SF ± SD (points)

11 ± 2.77

9.8 ± 2.84

0.003

Mean MNA total ± SD (points)

23.9 ± 4.1

21.4 ± 4.5

<0.001

2

2

G1 = Group 1, G2 = group 2, n = number of patients, SD = standard deviation, BMI = body mass index, LMMI = lean
muscle mass index, NRS 2002 = Nutritional Risk Screening 2002, MUST = Malnutrition Universal Screening Test,
MNA-SF = Mini Nutritional Assessment Short Form.
*Student’s t-test, ** chi-square test.

Table 3. Malnutrition risk and sarcopenia rates of all of the patients based on nutrition tests.
Group 1, n (%)

Group 2, n (%)

P-value*

NRS 2002 MR

12 (14.3)

45 (40.5)

<0.001

MUST MR

15 (18)

33 (30)

0.057

MNA screening MR

37 (44)

79 (71)

0.001

MR

28 (33)

59 (68)

<0.001

Malnutrition

5 (6)

19 (17)

Sarcopenia

4 (5)

37 (33)

Presarcopenia

1 (1.2)

3 (2.7)

Sarcopenia/severe sarcopenia

3 (3.6)

34 (30.4)

Nutritional status

MNA total

<0.001

n = Number of patients, MR: malnutrition risk, NRS 2002 = Nutrition Risk Screening 2002, MUST = Malnutrition
Universal Screening Test, MNA = Mini Nutritional Assessment.
*Chi-square test.
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presence of malnutrition with sarcopenia, according to the
total MNA scores of all patients. The three malnutrition
tests were compared with ROC curve analysis between
the groups in terms of sarcopenia, sarcopenia parameters
(LMMI, hand grip strength, and walking speed), and
prolonged hospitalization periods. Among the three
screening tests, the MNA-SF was better at detecting
sarcopenia in G1 (AUC = 0.716, P = 0.147; sensitivity
63%, specificity 64%); however, the differences were not
statistically significant (Figure 1a). In G2, the MNA-SF was
more significantly related to the presence of sarcopenia
than the other tests (Figure 1b). In G1, the MNA-SF was
a better indicator of a prolonged hospitalization period
than the other tests (AUC = 0.585, P = 0.26; sensitivity
41%, specificity 44%); however, the differences were not
statistically significant (Figure 2a). The MUST was a better
evaluator of a prolonged hospitalization in G2 (AUC =
0.614, P = 0.048; sensitivity 25%, specificity 86%) (Figure
2b).
When the sarcopenia parameters are compared among
the three screening tests, LMMI results were the same
with sarcopenia (Figure 1a and 1b). Although hand grip
strength in the two groups was evaluated more efficiently
with the MNA-SF than with the other tests, the differences
were not statistically significant (AUC = 0.584, P = 0.18;
sensitivity 46%, specificity 70%, and AUC = 0.594, P = 0.27;
sensitivity 65%, specificity 50%, respectively). In addition,

the MNA-SF was better than the other tests at evaluating
low walking speed; however, there were no statistical
differences. In G2, low walking speed was correlated
more closely with the MNA-SF than with the other tests
in terms of statistical significance (AUC = 0.642, P = 0.01;
sensitivity 71%, specificity 47%).
4. Discussion
In this cross-sectional study, the malnutrition risk and
malnutrition rate of patients under the age of 65 were
33% and 6.65%, respectively; the malnutrition risk and
malnutrition rate of patients over the age of 65 were 68%
and 17%, respectively, which were both quite high.
The prevalence of sarcopenia was 5% under the age of
65 but 33% over the age of 65. Sarcopenia and/or severe
sarcopenia occurred in almost 30% of the patients in the
elderly group. In a study of 104 patients hospitalized in a
geriatrics inpatient clinic, the malnutrition risk was 48%
and the malnutrition rate was 22%, which is similar to the
results of our study (14). The malnutrition risk was found
to be 38.6% in another study (13).
It has been reported that the MUST is statistically
significant in the estimation of prolonged hospitalization
periods and high mortality rates (P = 0.02, P < 0.01,
respectively) (12). In our study, although the three tests
that evaluate nutritional status in hospitalized patients
were similar in terms of prolonged hospitalization periods

Figure 1a. Comparison of the three tests in terms of presence of sarcopenia in Group 1 patients (AUC = 0.613, P = 0.450, sensitivity
12.5%, specificity 90% for NRS 2002; AUC = 0.522, P = 0.883, sensitivity 25%, specificity 88% for MUST; AUC = 0.716, P = 0.147,
sensitivity 63%, specificity 64% for MNA-SF) (AUC = area under the curve, NRS 2002 = Nutritional Risk Screening 2002, MUST =
Malnutrition Universal Screening Test, MNA-SF = Mini Nutritional Assessment Short Form).
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Figure 1b. Comparison of the three tests in terms of presence of sarcopenia in Group 2 patients (AUC = 0.689, P = 0.001, sensitivity 44%,
specificity 78% for NRS 2002; AUC = 0.659, P = 0.006, sensitivity 36%, specificity 86% for MUST; AUC = 0.762, P < 0.001, sensitivity
86%, specificity 48% for MNA-SF) (AUC = area under the curve, NRS 2002 = Nutritional Risk Screening 2002, MUST = Malnutrition
Universal Screening Test, MNA-SF = Mini Nutritional Assessment Short Form).

Figure 2a. Comparison of the three tests in terms of prolonged hospitalization periods (≥15 days) in Group 1 (AUC = 0.495, P = 0.945,
sensitivity 10%, specificity 89% for NRS 2002; AUC = 0.540, P = 0.597, sensitivity 14%, specificity 92% for MUST; AUC = 0.585, P =
0.259, sensitivity 41%, specificity 47% for MNA-SF) (AUC = area under the curve, NRS 2002 = Nutritional Risk Screening 2002, MUST
= Malnutrition Universal Screening Test, MNA-SF = Mini Nutritional Assessment Short Form).

1367

YÜRÜYEN et al. / Turk J Med Sci

Figure 2b. Comparison of the three tests in terms of prolonged hospitalization periods (≥15 days) in Group 2 (AUC = 0.488, P = 0.827,
sensitivity 33%, specificity 74% for NRS 2002; AUC = 0.614, P = 0.048, sensitivity 25%, specificity 86% for MUST; AUC = 0.514, P =
0.789, sensitivity 66%, specificity 41% for MNA-SF) (AUC = area under the curve, NRS 2002 = Nutritional Risk Screening 2002, MUST
= Malnutrition Universal Screening Test, MNA-SF = Mini Nutritional Assessment Short Form).

in patients under the age of 65, the MUST was better at
estimating prolonged hospitalization periods in patients
over the age of 65. However, the MUST has high specificity
but low sensitivity with respect to the cutoff points (≥2
points) of malnutrition risk. In a comprehensive study of
705 patients admitted to hospitals in a Brazilian population
that aimed to compare the three tests (NRS 2002, MUST,
and MNA-SF), malnutrition risks were found to be
27.9%, 39.6%, and 73.2%, respectively. In that study, ROC
curve analysis found that the NRS 2002 (complications:
0.6531 (AUC); prolonged hospitalization period: 0.6508;
mortality: 0.7948) and the MNA-SF (complications: 0.6495;
prolonged hospitalization period: 0.6197; mortality:
0.7583) were similar in terms of evaluating negative
results, such as complications, prolonged hospitalization
periods, and mortality. However, the NRS 2002 seemed to
be more predictable. Furthermore, there was no statistical
significance in patients under the age of 65 (P > 0.05) (15).
However, our study showed that compared with the other
tests, the MUST was significantly better in the evaluation
of prolonged hospitalization in elderly patients. We were
not able to compare the three tests in terms of mortality
in our study because the mortality rate was only 1% (two
patients).
We compared all three tests using ROC curve analysis
to predict the presence of sarcopenia due to the easy
applicability of the tests and because of the malnutrition–
sarcopenia relationship. We found that although the three
tests were significantly effective in representing sarcopenia
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in patients over the age of 65, the MNA-SF seemed to be
more effective than the other tests (MNA-SF, P < 0.001;
NRS 2002, P = 0.001; MUST, P = 0.006). None of the three
tests are highly sensitive or specific in terms of detecting
the presence of sarcopenia and sarcopenia parameters.
However, the MNA-SF does well in patients over the age
of 65 with low LMMI and who have a slow walking speed.
The study results showed that the tests are similar in low
hand grip strength in the two age groups.
The limitations of our study are as follows: the study is
local and cross-sectional. The “timed get up and go” test to
assess walking speed in hospitalized patients could not be
performed by some patients because of their poor physical
condition. Thus, mean walking speed might actually be
lower than expected. Patients hospitalized in the oncology,
hematology, and rheumatology clinics were excluded
from the study due to their poor performance status and
difficulty performing the tests. This factor might affect
conditions such as malnutrition, sarcopenia, mortality,
and a prolonged hospitalization period. The number of
patients, especially in G1 (n = 4), was low for evaluating
sarcopenia and differences between the tests. Finally,
the tools used to detect sarcopenia have no cutoff points
assigned for the Turkish population. For this reason, we
presented our results by comparing a smaller number of
controls (30 females and 30 males).
In conclusion, nutritional risk screening tools can
indicate the negative consequences of hospitalized patients.
The MNA-SF test is better at predicting sarcopenia

YÜRÜYEN et al. / Turk J Med Sci
and sarcopenia parameters in patients over the age of
65, whereas the MUST seems to be better at reflecting
prolonged hospitalization periods. However, while some
tests are shown to be effective according to the literature
and our study, it should be noted that these tests are not
as highly selective and specific as expected. Our study

is important in that it is the first study in the literature
to compare the three tests in terms of sarcopenia and
sarcopenia parameters. However, comprehensive studies
with a higher number of patients conducted at more than
one center need to be performed in the future.
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